Table 1.
Factors | N | % |
---|---|---|
Gender | ||
Male | 78 | 70.3% |
Female | 33 | 29.7% |
Age | ||
Median, range | 57.7, 39–84 | |
Primary Tumor Site | ||
Oropharynx | 55 | 49.6% |
Hypopharynx | 8 | 7.2% |
Larynx | 15 | 13.5% |
Oral Cavity | 8 | 7.2% |
Nasopharynx | 10 | 9.0% |
Unknown Primary | 15 | 13.5% |
T-stage | ||
T0 | 15 | 13.5% |
T1 | 30 | 27.0% |
T2 | 31 | 27.9% |
T3 | 25 | 22.5% |
T4 | 10 | 9.0% |
N-stage | ||
N0 | 20 | 18.0% |
N1 | 18 | 16.2% |
N2 | 58 | 48.6% |
N3 | 15 | 13.5% |
Overall Stage | ||
1 | 2 | 1.8% |
2 | 9 | 8.1% |
3 | 25 | 22.5% |
4 | 75 | 67.6% |
Treatment | ||
Primary CRT/RT | 99 | 89.2% |
Primary Surgery; post CRT/RT | 12 | 10.8% |
Post CRT ND | ||
No | 76 | 68.5% |
Yes | 35 | 31.5% |
Size of Stenosis | ||
≤ 5mm | 21 | 18.9% |
> 5mm | 68 | 61.3% |
Complete | 22 | 19.8% |